Chief Medical Officer

LSD shows promise for reducing anxiety in drugmaker's midstage study

Ticker: Acid passes stress test; Trump appeals tariff case to Supreme Court

Mind Medicine announces publication of results from MM120 Phase 2b study

LSD can help reduce anxiety, new study finds

Director, Statistical Programming

MindMed is a clinical stage biopharmaceutical company focused on developing innovative treatments for brain health disorders. As the Director of Statistical Programming, you will lead the Statistical Programming group, ensuring high-quality analysis datasets and supporting clinical development and regulatory activities.

Sign up with Google

Sign in with Google